Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 3;10(3):363-366.
doi: 10.1093/jpids/piaa089.

Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles

Affiliations

Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles

Sanya J Thomas et al. J Pediatric Infect Dis Soc. .

Abstract

We present the first published case of raltegravir-associated drug-reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a child without characteristic human leukocyte antigen haplotypes HLA-B*57:01 or HLA-B*53:01. A 4-year-old African American female with perinatally acquired human immunodeficiency virus infection was hospitalized for DRESS after starting a raltegravir-based antiretroviral regimen.

Keywords: antiretroviral therapy; drug-reaction with eosinophilia and systemic symptoms syndrome; human immunodeficiency virus; human leukocyte antigen-B alleles; raltegravir.

PubMed Disclaimer

Similar articles

References

    1. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol 2013; 68:693 e1–14; quiz 706–8. - PubMed
    1. Cacoub P, Musette P, Descamps V, et al. . The DRESS syndrome: a literature review. Am J Med 2011; 124:588–97. - PubMed
    1. Brandariz D, Smithson A, Anton-Vazquez V. Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients. Indian J Sex Transm Dis AIDS 2017; 38:163–70. - PMC - PubMed
    1. Carr DF, Chaponda M, Jorgensen AL, et al. . Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population. Clin Infect Dis 2013; 56:1330–9. - PMC - PubMed
    1. Mallal S, Nolan D, Witt C, et al. . Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359:727–32. - PubMed